在帕金森病中震的临床概况
Jacopo Pasquini1,2, Günther Deuschl3, Alessandro Pecori4
1Department of Clinical and Experimental Medicine Pisa University Pisa Italy.
Movement disorders clinical practice
|October 23, 2023
概括
帕金森病 (PD) 的震随着时间的推移而恶化,许多患者对多巴胺作用药物的反应很小. 这项研究为了解PD震的自然史和指导未来研究提供了一个框架.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
- 帕金森病研究 帕金森病研究
背景情况:
- 震是帕金森病 (PD) 的重要且经常使人衰弱的症状.
- 对于多巴胺类药物的PD震的反应是不一致的,强调需要更好的理解.
- 目前缺乏基于证据的框架来管理PD震.
研究的目的:
- 纵向分析在新发帕金森病中震的临床特征.
- 为了检查7年内休息,姿势和运动震的进展.
- 为了评估PD震对多巴胺类药物的反应.
主要方法:
- 分析了397名来自帕金森进步标志物倡议队列的参与者.
- 在7年内使用MDS-UPDRS进行震分数 (休息,姿势,动力) 的纵向评估.
- 用于分析震进展和药物反应的线性混合效应模型,对共变量进行调整.
主要成果:
- 超过96%的参与者表现出,其中87%显示出休息.
- 休息,姿势和运动震得分在7年随访期间显著增加.
- 显著的百分比的参与者 (20-38%) 显示不响应多巴胺类药物治疗不同类型的震.
结论:
- 帕金森病是一个渐进的和麻烦的症状,药物反应变化.
- 这项研究建立了早期到中期PD震的临床自然史.
- 这些发现为未来对PD震病理生理学和治疗的研究提供了基于证据的框架.
相关概念视频
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Alzheimer's Disease: Overview
500
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
500
REM Sleep Behavior Disorder
211
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
211
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14


